Tag: Stockholm:ALVO.SDB.ST

Transactions of Managers and Closely Associated Persons

Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding a transaction of managers and closely associated persons, announcing the allocation of shares to a director of the board of Alvotech in accordance with his remuneration package.

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

REYKJAVIK, Iceland, June 08, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Biologics License Application (BLA) for AVT16, a proposed interchangeable biosimilar to Entyvio^® (vedolizumab) lyophilized vial for intravenous administration.

- A word from our sponsors -

HomeTagsStockholm:ALVO.SDB.ST

New Free-to-Play Competition Format Arrives for the World Soccer Cup

O’Shaughnessy Ventures Backs Bioengineer Downloading New Functions into Biological Cells

EventPipe™ Names Dillon Blake Chief Revenue Officer to Accelerate Multi-Market Growth

Tag: Stockholm:ALVO.SDB.ST

Transactions of Managers and Closely Associated Persons

Alvotech announces FDA acceptance of Biologics License Application for AVT16, a proposed interchangeable biosimilar to Entyvio®

Explore

Press Releases

News & Opinion

Living

Others

Follow us